Good Lifestyle

At this moment, Pfizer and Moderna are the only onesTwo coronavirus vaccines which have been authorized by the Food and Drug Administration (FDA). However, another Covid vaccine isshould reach the authorization scene soon Johnson & Johnson. Unlike others, this vaccine is only a dose - but according to new research, it can work as well as the others. New test data published on January 13 in theNew England Journal of Medicineinformation liberated on the safety, efficiency and possible side effects ofThe new Johnson & Johnson vaccine.

During the trial, researchers with Johnson & Johnson attributed 805 random participants to receive a high or low dose of the vaccine, called AD26.COV2.S-or placebo. Researchers have studied two age groups during this trial: healthy adults aged 18 to 55 and aged 65 and over. According to the study, 90% or more of all participants had neutralized antibodies 29 days after being vaccinated and 100% had antibodies 57 days after obtaining their vaccine.

And while the enthusiasm on the potential to get your Covid vaccination carried out within one shot is justified, like any other vaccine, you shouldExpect potential side effects. According to the study, there are five common side effects that can come from the new Johnson & Johnson's new Covid vaccine, which is sufficiently interesting, was more widely frequent in those 18 to 55 than those aged 65 and over. Keep reading to find out what they are, and for more vaccines, know thatIf you take these over-the-counter medes, you must stop before getting the vaccine.

Read the original article onBetter life.

In trial participants aged 18 to 55, aThe fever has been reported as a side effect For 20% of those who received a low dose and 48% of those who received a high dose. Of these 65 years and over, only 4% of low-dose beneficiaries and 10% of high-dose beneficiaries reported having had fever. "All cases of fever took place within 2 days of vaccination and resolved within 1 or 2 days," noted researchers in their study. And for the symptoms that you can experiment with the virus itself, discoverThe first signs you have COVID, according to Johns Hopkins.

Johnson & Johnson test participants who received a low vaccine dose, nearly 45% of those 18 to 55 and nearly 30% of these 65 years and overReported fatigue as a side effect. For those aged 18 to 55 who received the higher dose, about 70% were experienced fatigue. And for those aged 65 and over with a high dose, 40% had this reaction. And for more fatigue, beware thatIf you feel tired after that, you may have had Covid.

For JOHNSON & JOHNSON study topics between 18 and 55, about 45% in the low-dose group reportedto have a headache and 70% in the high-dose group experienced the same thing. A headache was less common in these 65 years and over. For those of this age group who received a low dose of the Johnson & Johnson vaccine, about 25% had the side effect and was reported by nearly 35% of those with a high dose. And for more information up to date,Sign up for our daily newsletter.

MuscleOtherwise known as myalgia, has been reported by 40% of the 18 to 55 years that received only a low dose of Johnson & Johnson vaccine. For the aged 65 and older who received a low dose, 20% reported myalgia. As for those who received the higher dose, about 60% of 18 to 55 years reported this side effect and 25% of people aged 65 and over. And for more coronavirus concerns, discover whyThis COVID protection measure is "does not work," warns the doctor.

Out of the three studied local adverse events - rashes, pain and swelling, only the pain seemed to be a common reaction among the participating Johnson & Johnson vaccination newspaper. For 18 to 55 years, almost 65% of those who received a low dose reported pain at the injection site and about 75% of those who received a high dose. And among those 65 and over, 40% of those who received the low dose and the high dose were pain at the injection site. And for more on the pandemic, take a look atThe 3 things that could prevent almost every case of Covid, studies.